KLLN and ovarian carcinoma: Hu et al. (2016) further illustrated KLLN protein’s (Killin, P53 Regulated DNA Replication Inhibitor) suppression via MIR224, which fostered a downstream target, cyclin A, to initiate proliferation in epithelial ovarian cancer cells [74].